Inhibitors of S1PR1 are used to treat inflammatory diseases such as multiple sclerosis and IBD, which are diseases that are likely modulated by the lymphatic vasculature (Cartier and Hla, 2019; Oliver et al., 2020). Here, S1PR1 is linked to multiple sclerosis.